Potent and Selective Conformationally Restricted Neuronal Nitric Oxide Synthase Inhibitors

Journal of Medicinal Chemistry

Volumn 47, Issue 3, 2004, Pages 703-710

  Gómez Vidal, José A ^a   Martásek, Pavel ^b   Roman, Linda J ^b   Silverman, Richard B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TETRAHYDROBIOPTERIN;

ARTICLE; DEGENERATIVE DISEASE; DEPROTECTION REACTION; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; IC 50; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY;

ANIMALS; CATTLE; DIPEPTIDES; ISOENZYMES; MICE; MOLECULAR CONFORMATION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITROARGININE; RATS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 1642458673     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030297m     Document Type: Article

References (58)

1. Wink, D. A.; Miranda, K. M.; Espey, M. G.; Mitchell, J. B.; Grisham, M. B.; Fukuto, J.; Feelisch, M. The chemical biology of nitric oxide. Balancing nitric oxide with oxidative and nitrosative stress. Handb. Exp. Pharmacol. 2000, 143, 7-29.
2. Moncada, S.; Higgs, A.; Furchgott, R. XIV. International union of pharmacology nomenclature in nitric oxide research. Pharmacol. Rev. 1997, 49, 137-142.
3. Hobbs, A. J.; Higgs, A.; Moncada, S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu. Rev. Pharmacol. Toxicol. 1999, 39, 191-220.
4. Li, H.; Raman, C. S.; Martásek, P.; Masters, B. S. S.; Poulos, T. L. Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors. Biochemistry 2001, 40, 5399-5406.
5. Hillier, B. J.; Christopherson, K. S.; Prehoda, K. E.; Bredt, D. S.; Lim, W. A. Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Science 1999, 284, 812-815.
6. Nishida, C. R.; Ortiz de Montellano, P. R. Electron transfer and catalytic activity of nitric oxide synthases. Chimeric constructs of the neuronal, inducible, and endothelial isoforms. J. Biol. Chem. 1998, 273, 5566-5571.
7. Siddhanta, U.; Presta, A.; Fan, B.; Wolan, D.; Rousseau, D. L.; Stuehr, D. J. Domain swapping in inducible nitric-oxide synthase. Electron transfer occurs between flavin and heme groups located on adjacent subunits in the dimer. J. Biol. Chem. 1998, 273, 18950-18958.
8. Crane, B. R.; Arvai, A. S.; Gachhui, R.; Wu. C.; Ghosh, D. K.; Getzoff, E. D.; Stuehr, D. J.; Tainer, J. A. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 1997, 278, 425-431.
9. ω-hydroxy-L-arginine complex of inducible nitric oxide synthase oxygenase dimer with active and inactive pterins. Biochemistry 2000, 39, 4608-4621.
10. Crane, B. R.; Arvai, A. S.; Ghosh, D. K.; Wu. C.; Getzoff, E. D.; Stuehr, D. J.; Tainer, J. A. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 1998, 279, 2121-2126.
11. Fischmann, T. O.; Hruza, A.; Niu, X. D.; Fossetta, J. D.; Lunn, C. A.; Dolphin, E.; Prongay, A. J.; Reichert, P.; Lundell, D. J.; Narula, S. K.; Weber, P. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat. Struct. Biol. 1999, 6, 233-242.
12. Li, H.; Raman, C. S.; Glaser, C. B.; Blasko, E.; Young, T. A.; Parkinson, J. F.; Whitlow, M.; Poulos, T. L. Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. J. Biol. Chem. 1999, 274, 21276-21284.
13. Raman, C. S.; Li, H.; Martásek, P.; Král, V.; Masters, B. S. S.; Poulos, T. L. Crystal structure of constitutive endothelial nitric oxide synthase: A paradigm for pterin function involving a novel metal center. Cell 1998, 95, 939-950.
14. Gerber, N. C.; Rodriguez-Crespo, I.; Nishida, C. R.; Ortiz de Montellano, P. R. Active site topologies and cofactor-mediated conformational changes of nitric-oxide synthases. J. Biol. Chem. 1997, 272, 6285-6290.
15. Alcaraz, M. J.; Guillen, M. I. Nitric oxide related therapeutic phenomenon: A challenging task. Curr. Pharm. Des. 2002, 8, 215-231.
16. (a) Vallance, P.; Leiper, J. Blocking NO synthesis: How, where and why? Nat. Rev. Drug Discuss. 2002, 1, 939-950.
17. (b) Grunewald, T.; Beal, M. F. NOS knockouts and neuroprotection. Nat. Med. 1999, 5, 1354-1355.
18. Huang, Z.; Effects of cerebral ischaemia in mice deficient in neuronal nitric oxide synthase. Science 1994, 265, 1883-1885.
19. Ashina, M. Nitric oxide synthase inhibitors for the treatment of chronic tension-type headache. Expert Opin. Pharmacother. 2002, 3, 395-399.
20. Schulz, J. B.; Matthews, R. T.; Klockgether, T.; Dichgans, J.; Flint B., M. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol. Cell. Biochem. 1997, 174, 193-197.
21. Lowe, J. A., III. Nitric oxide synthase inhibitors: Recent patent activity. IDrugs 2000, 3, 63-72.
22. Boughton-Smith, N. K.; Tinker, A. C. Inhibitors of nitric oxide synthase in inflammatory arthritis. IDrugs 1998, 1, 321-333.
23. Kankuri, E.; Vaali, K.; Knowles, R. G.; Lahde, M.; Korpela, R.; Vapaatalo, H.; Moilanen, E. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(Aminomethyl)benzyl]acetamidine. J. Pharmacol. Exp. Ther. 2001, 298, 1128-1132.
24. Tinker, A. C.; Beaton, H. G.; Boughton-Smith, N.; Cook, T. R.; Cooper, S. L.; Fraser-Rae, L.; Hallam, K.; Hamley, P.; McInally, T.; Nicholls, D. J.; Pimm, A. D.; Wallace, A. V. 1,2-Dihydro-4-quinazolinamines: Potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo. J. Med. Chem. 2003, 46, 913-916.
25. Salerno, L.; Sorrenti, V.; Di Giacomo, C.; Romeo, G.; Siracusa, M. A. Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr. Pharm. Des. 2002, 8, 177-200.
26. γ-propyl-L-arginine. J. Med. Chem. 1997, 40, 3869-3870.
27. 5-(imino-3-butenyl)-L-ornithine. A neural isoform selective mechanism-based inactivator of nitric oxide synthase. J. Biol. Chem. 1998, 273, 8882-8889.
28. Hagen, T. J.; Bergmanis, A. A.; Kramer, S. W.; Fok, K. F.; Schmelzer, A. E.; Pitzele, B. S.; Swenton, L.; Jerome, G. M.; Kornmeier, C. M.; Moore, W. M.; Branson, L. F.; Connor, J. R.; Manning, P. T.; Currie, M. G.; Hallinan, E. A. 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase. J. Med. Chem. 1998, 41, 3675-3683.
29. Collins, J. L.; Shearer, B. G.; Oplinger, J. A.; Lee, S.; Garvey, E. P.; Salter, M.; Duffy, C.; Burnette, T. C.; Furfine, E. S. N-Phenylamidines as selective inhibitors of human neural nitric oxide synthase: Structure-activity studies and demostration of in vivo activity. J. Med. Chem. 1998, 41, 2858-2871.
30. Garvey, E. P.; Oplinger, J. A.; Furfine, E. S.; Kiff, R. J.; Laszlo, F.; Whittle, B. J.; Knowless, R. G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 1997, 272, 4959-4963.
31. McMillan, K.; Adler, M.; Auld, D. S.; Baldwin, J. J.; Blasko, E.; Browne, L. J.; Chelsky, D.; Davey, D.; Dolle, R. E.; Eagen, K. A.; Erickson, S.; Feldman, R. I.; Glaser, C. B.; Mallari, C.; Morrissey, M. M.; Ohlmeyer, M. H. J.; Pan, G.; Parkinson, J. F.; Phillips, G. B.; Polokoff, M. A.; Sigal, N. H.; Vergona, R.; Whitlow, M.; Young, T. A.; Devlin, J. J. Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 1506-1511.
32. Park, J.-M.; Higuchi, T.; Kikuchi, K.; Urano, Y.; Hori, H.; Nishino, T.; Aoki, J.; Inoue, K.; Nagano, T. Selective inhibition of human inducible nitric oxide synthase by S-alkyl-L-isothiocitrulline-containing dipeptides. Br. J. Pharmacol. 2001, 132, 1876-1882.
33. Kobayashi, N.; Higuchi, T.; Urano, Y.; Kikuchi, K.; Hirobe, M.; Nagano, T. Dipeptides containing L-arginine anologues: new isozyme-selective inhibitors of nitric oxide synthase. Biol. Pharm. Bull. 1999, 22, 936-940.
34. Narayanan, K.; Griffith, O. W. Synthesis of L-thiocitrulline, L-homothiocitrulline, and S-methyl-L-thiothitrulline: a new class of potent nitric oxide synthase inhibitors. J. Med. Chem. 1994, 37, 885-887.
35. G-nitroarginine. Biochemistry 1993, 32, 8512-8517.
36. ω-nitroarginine- and phenylalanine-containing dipeptides and dipeptide esters. J. Med. Chem. 1997, 40, 2813-2817.
37. ω-nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neural nitric oxide synthase. J. Med. Chem. 1999, 42, 3147-3153.
38. Flinspach, M.; Li, H.; Jamal, J.; Yang, W.; Huang, H.; Hah, J.-M.; Gómez-Vidal, J. A.; Litzinger, E A.; Silverman, R. B.; Poulos, T. L. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase. Nat. Struct. Biol., in press.
39. Gómez-Vidal, J. A.; Silverman, R. B. Short, highly efficient syntheses of protected 3-azido- and 4-azidoproline and their precursors. Org. Lett. 2001, 3, 2481-2484.
40. Zhang, A. J.; Russell, D. H.; Zhu, J.; Burgess, K. A method for removal of N-BOC protecting groups from substrates on TFA-sensitive resins. Tetrahedron Lett. 1998, 39, 7439-7442.
41. Emde, H.; Domsch, D.; Feger, H.; Frick, U.; Gotz, A.; Hergott, H. H.; Hoffmann, K.; Kober, W.; Kragelloh, K.; Oesterle, T.; Steppan, W.; West, W.; Simchen, G. Trialkylsilyl Perfluoro-alkanesufonates: Highly Reactive Silylating Agents and Lewis Acids in Organic Synthesis. Synthesis 1982, 1, 1-26.
42. Ohfune, Y.; Salaitani, M. Syntheses and Reactions of Silyl Carbamates. 1. Chemoselective Transformation of Amino Protecting Groups via tert-Butyldimethylsilyl Carbamates. J. Org. Chem. 1990, 55, 870-876.
43. Gololobov, Y. G.; Kasukhin, L. F. Recent advances in the Staudinger reaction. Tetrahedron 1992, 48, 1353-1406.
44. Lott., R. S.; Chauhan, V. S.; Stammer, C. H. Trimethylsilyl iodine as a peptide deblocking agent. J. Chem. Soc., Chem. Commun. 1979, 495-496.
45. Nicolaou, K. C.; Koumbis, A. E.; Takayanagi, M.; Natarajan, S.; Jain, N. F.; Bando, T.; Li, H.; Hughes, R. Total synthesis of vancomycin-Part 3: Synthesis of the aglycon. Chem.-Eur. J. 1999, 5, 2622-2647.
46. Desai, P.; Schildknegt, K.; Agrios, K. A.; Mossman, C.; Milligan, G. L.; Aube, J. Reactions of alkyl azides and ketones as mediated by Lewis acids: Schmidt and Mannich reactions using azide precursors. J. Am. Chem. Soc. 2000, 122, 7226-7232.
47. - Species. Tetrahedron 1990, 46, 587-594.
48. Kim, J.; Bi, Y., Paikoff, S. J.; Schultz, P. G. The solid-phase synthesis of oligoureas. Tetrahedron Lett. 1996, 37, 5305-5308.
49. (a) Kick, E.; Ellman, J. A. Expedient method for the solid-phase synthesis of aspartic acid protease inhibitors directed toward the generation of libraries. J. Med. Chem. 1995, 38, 1427-1430.
50. (b) Tortolani, D. R.; Biller, S. A. A solid-phase synthesis of miconazole analogs via an iodoetherification reaction. Tetrahedron Lett. 1996, 37, 5687-5690.
51. Greene, T. W. and Wuts, P. G. M. Protective groups in organic synthesis; John Wiley & Sons: New York, 1999; p 556.
52. Katritzky, A. R., Yang, B., Semenzin, D. (Trifluoroacetyl)-benzotriazole: A convenient trifluoroacetylating reagent. J. Org. Chem. 1997, 62, 726-728.
53. Huang, H.; Martasek, P.; Roman, L. J.; Silverman, R. B. Synthesis and evaluation of peptidomimetics as selective inhibitors and active site probes of nitric oxide synthases. J. Med. Chem. 2000, 43, 2938-2945.
54. Hevel, J. M.; White, K. A.; Marletta, M. A purification of the inducible murine macrophage nitric oxide synthase. J. Biol. Chem. 1991, 266, 22789-22791.
55. Roman, L. J.; Sheta, E. A.; Martasek, P.; Gross, S. S.; Liu, Q.; Masters, B. S. S. High-level expression of functional rat neuronal nitric oxide synthase in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 8428-8432.
56. Martasek, P.; Liu, Q.; Roman, L. J.; Gross, S. S.; Sessa, W. C.; Masters, B. S. S. Characterization of bovine endothelial nitric oxide synthase expressed in Escherichia coli. Biochem. Biophys. Res. Commun. 1996, 219, 359-365.
57. Hevel, J. M.; Marletta, M. A. Nitric oxide synthase assays. Methods Enzymol. 1994, 133, 250-258.
58. Segel, I. H. Enzyme Kinetics; John Wiley and Sons: New York, 1975; p 105.